Six different Bacillus cereus strains were selected from two different ecotypes: (1) three commonly used laboratory strains that are considered avirulent, and (2) three clinical isolates from meningitis patients. Screening of genomic DNA for the presence of genes encoding known toxins gave no candidate genes that were unambiguously able to distinguish between the two groups. However, the application of multivariate pattern-recognition methods to metabolite profiles derived from the different strains using 1 H nuclear magnetic resonance spectroscopy (metabolomics) was able to classify the different profiles. The two different ecotypes were clearly separated on the basis of their metabolite profiles, showing that it is possible to use metabolomic methods to classify pathogens on the basis of their expressed physiology, even when it is not possible to infer a direct mechanistic link to specific virulence factors. This metabolomic approach could also have a wide range of possible applications in both general microbiology and microbial ecology for distinguishing and identifying different functional/physiological ecotypes of bacterial strains or species.
Introduction
Bacillus cereus is considered to be an opportunistic human pathogen which can cause infections of varying severity. Most commonly associated with self-limiting gastrointestinal infections caused by the production of enterotoxins, B. cereus can also cause a range of nongastrointestinal diseases ranging from severe eye infections to potentially fatal bacteraemias and meningitis [1, 2] . The genetic background of these pathogenic strains is extremely similar. It has been suggested that this bacterium could be regarded as the same species as two other members of the B. cereus group: the agriculturally important B. thuringiensis and the mammalian pathogen B. anthracis (the causative agent of anthrax), with distinctions between them solely due to the possession of plasmid-borne virulence genes [3] [4] [5] . It is therefore of great importance to be able to distinguish between stains that are harmless, or of low risk only, from strains that may be hazardous pathogens [6] .
There are several possible approaches that could be implemented for non-targeted profiling of the ecophysiological state, or ÔpathotypeÕ, of a bacterial strain. However, there are several advantages to the use of metabolomic profiling for this application. Metabolomics is based on the comprehensive analysis of the lowmolecular-weight metabolite complement of a biological sample. Because metabolites are downstream of both gene transcription and enzyme activities, metabolomics has the potential to give a more accurate picture or snapshot of the actual physiological state of a cell or cells [7] . Metabolomics has been used for studying the response of bacteria to different physiological states and stressors [8] [9] [10] , and some studies have shown recently that NMR-based profiling can be used for microbial species differentiation and classification, including in vivo profiling of yeast strains and magic-angle-spinning profiling of marine unicellular algae [11, 12] . It has also been shown that individual strains of Saccharomyces cerevisiae with single-gene deletions can be distinguished by metabolomics, and that strains with gene deletions from closely-related areas of metabolism clustered together in metabolic space [13, 14] . It can therefore be inferred that metabolomics could potentially be used as an aid for the profiling and possible classification of microbial strains into groups of functional/clinical significance. We aimed in this study to test if metabolomic profiling could prove a useful complement to existing methods of profiling and typing members of the B. cereus group, and, in particular, if it were possible to differentiate strains on the basis of their pathogenic potential. Previous metabolomic studies with bacteria have used model organisms and well-defined stresses or growth effects [8] [9] [10] . This study is, therefore, the first example of metabolomic profiling of multiple strains of bacteria to address a significant physiological/clinical problem.
We selected six different B. cereus strains from two different pathotypes -three laboratory strains considered generally non-pathogenic, and three clinical isolates taken from meningitis patients -to profile both for the presence of known virulence genes, and also for non-targeted NMR-based metabolomic profiling. The aims of this experiment were thus to collect metabolite profiles from the different strains and then apply multivariate pattern-recognition methods to the spectral data in order to determine (1) if individual bacterial strains were separated in metabolic space, i.e. could be distinguished on the basis of their metabolic profiles, and (2) if the different pathotypes were clustered on the basis of their metabolic differences. If such differences were found, they could form the basis of a predictive model for classification of strains. This can be formally stated, such that the null hypothesis is that there are no metabolite patterns characteristic of the different B. cereus pathotypes.
Materials and methods

Bacterial strains
The bacterial strains used in this study belonged to one of two groups, either Ônon-pathogenicÕ laboratory strains, or else clinical isolates. The laboratory strains were B. cereus Type Strain ATCC 14579 (referred to as TS in this paper for brevity), B. cereus 569 and B. cereus T. The pathogenic strains were B. cereus SJ4, B. cereus SJ10 and B. cereus SJ12. The pathogenic strains were all isolated from immunocompromised acute lymphoblastic leukaemia patients from the same hospital (St. Jude ChildrenÕs Research Hospital, Memphis) but from independent outbreaks of infection (occurring in 1997, 1999 and 1999 respectively). Details are given in [15] and [16] . The selection of isolates from different outbreaks was to avoid simple re-testing of different isolates of the same bacterial strain (testing multiple isolates of the same strain would provide a much less stringent test of the hypothesis). Strains were maintained as 15% glycerol stocks at À80°C.
Cell growth and metabolite extraction
Individual colonies were taken from freshly-streaked Luria Bertani (LB) agar plates. Cells were grown in batch culture in LB broth. An initial pre-culture (20 ml LB, 16 h, 30°C, shaking at 200 rpm) was used in every case to reduce differences caused by colony selection. An inoculum of 1% was then made into 50 ml of fresh LB broth, and the cells grown to the onset of stationary phase (approximately 4 h). The cell cultures were quenched by placing on ice for a few minutes, then centrifuged (2000g, 5 min, 4°C), and the supernatant decanted. The cell pellet was then washed twice in 20 ml of ice-cold PBS (centrifugation conditions as before). The cells were extracted in 5 ml of hot 75% ethanol solution, with the addition of 2 ml of 0.3 mm glass beads, by vortexing for 30 s, heating for 4 min in a boiling water bath, and vortexing again for 30 s. The supernatant was then centrifuged (10 min, 16,000g) and dried on a rotary concentrator, and samples stored at À80°C until analysis. All extractions were carried out in triplicate and two independent extractions were performed on different dates, giving six replicate extracts per strain.
PCR Screening
Genomic DNA was isolated from all B. cereus strains according to the method of Pospiech and Neumann [17] . Briefly, cells were harvested from 30 ml overnight cultures via centrifugation (3000g, 5 min). Cell pellets were resuspended in 5 ml SET solution (75 mM NaCl, 25 mM EDTA, 20 mM Tris-HCl, pH 8.0), lysozyme added to a concentration of 1 mg/ml and incubated with shaking at 180 rpm for 2 h. Subsequently, 0.5 ml 10% sodium dodecyl sulfate and 4 mg proteinase K were added followed by incubation at 55°C with agitation for 2 h. DNA was extracted with chloroform by addition of 1.9 ml 5 M NaCl and 5.8 ml chloroform and incubation at room temperature for 30 min with occasional inversion. Phases were separated via centrifugation (3000g, 15 min). DNA in the aqueous phase was precipitated by addition of 1 volume isopropanol, washed with 70% ethanol and vacuum dried. DNA pellets were resuspended in TE buffer (10 mM Tris-HCl, 0.1 mM EDTA). RNA was degraded by addition of 0.5 lg DNase-free RNase (Roche) and incubation at 42°C for 1-2 h.
PCR for detection of known/putative virulence factor genes was performed using the primers and thermocycling parameters described in Table 1 . These protocols were preceded by an initial denaturation at 94°C for two minutes and followed by a final extension period at 72°C for two minutes. In the absence of a PCR product the annealing temperature was reduced to a minimum of 40°C in an attempt to overcome any mismatching of primers due to polymorphisms. Final reaction mixtures (50 ll) contained approx. 100 ng total DNA template, 1· PCR buffer (Amersham Pharmacia Biotech [10 mM Tris-HCl, pH 9.0, 1.5 mM MgCl 2 , and 50 mM KCl]), 200 lM of each dNTP, 25 pmol each of forward and reverse primers and 2 units Taq DNA polymerase (Amersham Pharmacia Biotech). PCR products (10 ll) were analysed by electrophoresis (80 V, approx. 1 h) in 1% agarose gel (0.5· TAE buffer) containing 1 mg/ml ethidium bromide.
NMR spectroscopy
Each sample was rehydrated in 0.8 ml of NMR buffer. The NMR buffer contained 100 mM phosphate buffer, pH 7.0, made up in 2 H 2 O, containing 0.5 mM sodium trimethylsilyl-2,2,3,3-2 H 4 -propionate (TSP). The 2 H 2 O provided a field frequency lock for the spectrometer and the TSP served as an internal chemical shift reference. The sample was then filtered through a 0.22 lm filter and 0.6 ml transferred to a 5 mm NMR sample tube. The samples were analysed on a Varian Unity spectrometer equipped with a 9.4 T magnet, giving an observational frequency for 1 H of 400 MHz. One-dimensional spectra were collected using a NOESYPRESAT sequence to saturate the signal from residual 1 H water protons. Multiple transients (typically 128) were collected into 32K data points over a spectral width of 8 kHz, and multiplied by an exponential apodization function equivalent to 0.5 Hz line broadening prior to Fourier transformation. Chemical shifts were referenced to zero using the TSP signal as an internal standard, and phase correction was performed manually. Two-dimensional correlated spectroscopy (COSY) was used for selected samples. Typically, 512 increments of 24-32 transients were collected over a spectral width of 5 kHz into 2K data points in the F2 dimension, with an associated acquisition time of 0.2 s and an additional T1 relaxation delay of 3.5 s.
Data analysis
Baseline correction (settings: spectral averaging, 30 points, noise = 2) and integration was carried out with ACDLabs 1D NMR processor 7.0 (ACD, Toronto, Canada). The spectra were binned into 0.01 ppm regions from 9.5 to 0.5 ppm, excluding the region 5.8-4.2 ppm which contained the suppressed water resonance, resulting in each spectrum being data-reduced to a vector of length 740. No other resonances were present in the excluded section. A data matrix was constructed with each row representing a sample, and each column representing a variable (i.e. NMR spectral region). Each row was normalized to a total value of 1000, in order to remove differences based solely on total spectral intensity. The data were then transformed by log(n + 1), which has the effect of reducing the undue influence of high-concentration metabolites, without causing problems by scaling up regions containing only noise [18, 19] . The mean-centred data were then analysed by principal components analysis (PCA) based on the covariance matrix, using the software Simca-P 9.0 (Umetrics AB, Umeå, Sweden). Canonical discriminant analysis was carried out using S-PLUS 2000; a factor was created in which each strain was a different level. The first 10 PC scores (which explained 78% of the variance in the data) were used as input for the discriminant analysis, in order to reduce the dimensionality of the dataset and hence prevent overfitting of the model.
Results
Growth characteristics
Monitoring growth curves of the different strains demonstrated that there were no statistically significant differences in growth rates in rich medium for five out of the six strains (one-way ANOVA, P = 0.63), with an average doubling time of 35.9 ± 1.2 min. The sixth strain, SJ4, had a significantly longer average doubling time of 39.1 ± 0.6 min (P = 0.019).
Genomic screen for suspected virulence factors
We screened for the presence/absence of a total of eleven different genes coding for known/putative virulence factors; the complete results are given in Table 2 . Nine of the eleven selected genes were present in all of the different strains. The two remaining genes -haemolysin II (hlyII) and cytotoxin K (cytK) -were each absent in two of the strains (SJ4 and SJ0, and 569 and SJ4 respectively). However, there was no obvious pattern of putative virulence genes that could be used to distinguish the clinical isolates from the laboratory strains. Indeed, three of the strains (TS, T, and SJ12) have identical gene profiles, with all of the genes present. 
NMR-based metabolite profiling
A number of sharp well-resolved peaks corresponding to small-molecule metabolites could be observed in the 1D 1 H spectrum for each of the strains (Fig. 1) . Many of these can be readily assigned based on existing chemical shift data in the literature [20, 21] , whereas other resonances are yet to be assigned. Two-dimensional COSY spectra of selected samples were used to aid resonance assignment (not shown). A list of assigned resonances is given in Table 3 . In addition, broad underlying resonances could be observed in parts of the aliphatic region of the spectra, most likely representing signals from macromolecules that were not precipitated by the hot ethanol extraction, such as small proteins/ polypeptides or extracellular polysaccharidic material. Representative spectra for each of the six strains are given in Fig. 1 . Although there are many resonances which are present in more than one strain, there are clear differences visible between the strains. In particular, levels of an unassigned metabolite with a doublet at d 1.65 and a possible multiplet at d 4.26 (with a COSY cross peak indicating spin-spin coupling between the two resonances) were highest in SJ12; citrulline was highest in strain T; glycinebetaine was highest in SJ4 and SJ10; and 569 had low relative concentrations of all aromatic compounds. There was a singlet resonance at d 1.44, which was only observed for the SJ10 strain. Glutamate was very low in concentration or absent in the 569 strain.
We used multivariate pattern-recognition methods as a more systematic method of analysing similarities and differences between the spectral profiles of the different strains. Principal components analysis (PCA) can be used to fit axes to a multivariate dataset, such that the first principal component (axis) explains the maximum amount of variance possible within the data, and each subsequent component is orthogonal to all previous components and explains the maximum amount of variance remaining. PCA is thus a method for reducing the dimensionality of a dataset; it can help visualize inherent patterns and clustering within the data. The scores plot of PC 1 against PC 2 (Fig. 2) shows that the different strains are indeed separated within principal component space and, furthermore, that the two different groups (laboratory strains and clinical isolates) tend to cluster together, with the laboratory strains possessing largely positive values for PC 1 and the clinical isolates possessing largely negative values.
A further multivariate investigation of the data was carried out using canonical discriminant analysis (CDA). Like PCA, this creates new axes that are linear Chemical shift (ppm) combinations of the original input variables, but unlike PCA the analysis is ÔsupervisedÕ, meaning that a prior assignment of sample class is made and the fitting algorithm then maximizes the ratio of between-group to within-group variance. The first 10 PC scores, which explain 78% of the variance within the dataset, were used as input for the CDA (this dimension reduction is necessary to prevent overfitting of the model that would occur if the original 740 NMR bins were used as input). The CDA model was constructed to discriminate between all six strains, i.e. a categorical variable (factor) was created with six levels, and each strain was assigned a different level. A plot of the first two CDA axes shows that the data are clearly separated into two main groups: the clinical isolates are completely separated from the laboratory strains along axis 1 ( Fig. 3(a) ). Axis 2 separates some of the strains within these two groups: SJ10 is very clearly separated from SJ4 and SJ12, and 569 is separated from the other two laboratory strains. The loadings of the multivariate analyses can be interrogated in order to discover which metabolites are primarily responsible for separation of the different groups. Fig. 3 shows a plot of the loadings for the CDA for the first two axes. There are four spectral regions which have especially high loadings (>j0. glycinebetaine. These resonances can then be examined to confirm that the differences detected by multivariate analysis correspond to genuine changes in observable metabolite concentrations. Thus, it is possible to confirm, for example, that glycinebetaine is particularly elevated in both the SJ4 and the SJ10 strains, while citrulline is high in the T strain.
Discussion
Genetic profiles
There was no candidate gene or genes that could be used to discriminate the laboratory strains from the clinical isolates. Indeed, some of the laboratory strains have identical gene profiles to some of the clinical isolates (TS and T, compared with SJ12). Furthermore, these genes are all potential virulence genes, and therefore differences where the clinical isolates possess fewer of these genes than the laboratory strains (e.g. TS and T were positive for all of the genes screened and 569 was lacking only the cytK gene) cannot be used to give a rational explanation of differences in pathogenic potential. Thus, although two out of the three clinical isolates lack the hlyII gene, while all of the laboratory strains possess it, this would seem a strange basis for a test of virulence potential.
However, there is little doubt that the unusual virulence of some strains has a genetic basis. In general, the only difference between B. cereus and the more hazardous pathogen B. anthracis is the possession of plasmid-borne virulence genes [3, 6] . There are two possibilities why, in the present study, we found no correlation between possession of virulence genes and observed pathogenicity. Firstly, we did not attempt to determine if there were differential expression of these genes in the selected strains, and if expression might vary under different conditions. Secondly, it is highly likely that there are significant genes that were simply not tested for. In a clinical setting, virulence will depend not only on the expression of proteotoxins, but also on a number of other genes conferring ability to survive within the host, such as cell adhesion, survival under different physiological conditions, motility, etc. [22] . This is a potential weakness to any traditional target-based scientific approach. The combination of non-targetted ÔomicÕ methods with traditional mechanistic experiments is one possible approach to resolving this problem.
Metabolomic analysis
Metabolomic analysis has several advantages as a tool for direct assessment of microbial phenotypes. Firstly, as primary metabolites are common to all living organisms, there is no need for prior sequence knowledge, unlike transcriptomics and proteomics. Even though the B. cereus genome has been sequenced [23] , metabolomics is currently more suited to higherthroughput analysis with many replicates than is microarray analysis, and would therefore be more appropriate as a screening tool. NMR-based profiling of metabolites has one major disadvantage as an analytical platform for metabolomics -its relative lack of sensitivity, with detection limits for individual metabolites in the low micromolar range -but conversely has several distinct advantages also. In particular, it is a practically universal detector for small molecule metabolites (providing they are present in sufficient concentration), and thus provides a genuinely non-targetted snapshot of microbial physiology.
In the current study, we have shown that metabolomic analysis can readily separate all of the different Bacillus strains profiled in multivariate metabolic space. This in itself is notable, given that they have a very similar genetic background (all strains are members of the B. cereus group), and specific gene-based profiling has shown no clear differences in possession of suspected virulence factors. More significantly still, there is a clear separation of the strains into different functional groups, or pathotypes. This is shown clearly by discriminant analysis of the data (Fig. 3) . The analysis is ÔsupervisedÕ: prior knowledge is used to assign the replicates (individual spectra) to strain group, and the algorithm then attempts to separate these groups within metabolic space. However, the clustering of the different strains relative to each other is effectively unsupervised as the different strains are treated solely as distinct groups [14] , i.e. there is no prior information given as to which functional group each strain belongs to. Hence the clear separation of the two different functional groups, clinical isolates and laboratory strains, along discriminant axis 1 ( Fig.  3(a) ) indicates that there are real and significant physiological differences between the two groups. In addition, PCA of the data (which is a completely unsupervised data analysis method) also shows that there is inherent patterning within the data that separate the two groups: the clinical isolates are almost completely separated from the laboratory strains within PCs one and two (Fig. 2) , although there is some overlap of the TS and the SJ10 data. Furthermore, it is apparent that the laboratory strains form effectively one cluster, whereas the clinical isolates are also separated along discriminant axis 2, with SJ10 being different to the other two strains. Closer examination of the strain-specific metabolite differences shows that there are no simple metabolic biomarkers of pathogenic potential, that is, there are no metabolites which are either increased or reduced in concentration in all of the clinical isolates compared to the laboratory strains. It is the overall multivariate profile that is characteristic of the different groups.
One obvious question is, what is the relationship between pathogenic potential and microbial physiology/ biochemistry as represented by the metabolomic profiles? It is tempting to speculate as to causes for the differences in metabolite concentrations, and in some cases ad hoc hypotheses can be derived that may explain observed metabolomic changes. For example, treatment of Escherichia coli cells with paraquat, a redox cycler that causes oxidative stress, caused increases in both glutathione and valine [8] . Increases in glutathione due to oxidative stress are unsurprising. The observed increase in valine was hypothesized to be a novel protective mechanism, in which reactive oxygen species convert valine to valine hydroperoxide. However these hypotheses are most valuable in situations where there is already considerable prior knowledge of the biochemistry of the system under study. Indeed, even in highly controlled situations with model organisms, it may be impossible to explain all changes [9, 10, 13, 14] . Consequently we have avoided creating such ad hoc hypotheses for the current experiment. Nonetheless, a metabolomic approach has great potential for suggesting new possible mechanisms for testing as part of a functional genomic strategy. There are likely to be many examples where metabolites play a direct role in regulation of pathogenesis -for instance, targetted metabolite analyses have recently been used to demonstrate that small molecule metabolites (dinucleoside polyphosphates) within pathogenic bacteria control their invasivity and ability to adhere to mammalian cells [24] .
The NMR-derived metabolic profiles are essentially reporting on the physiology of the bacterial strains. They are consequently highly context-dependent, and will be affected by choice of growth medium, phase of growth, temperature, etc. The relative differences between strains of different genetic backgrounds will therefore change depending on the experimental conditions, as is also the case for other post-genomic analyses [25] . One possibility in this study is that the strains T, TS, and 569 have been subject to inadvertent selection for ease of culturing under typical laboratory conditions. Their physiological status might therefore be altered slightly compared to the clinical isolates (and this difference detectable by metabolomic methods), even though the growth rates in rich medium were very similar (and not significantly different for five out of the six strains). This would, of course, be a potential problem for any scientific metric, but is particularly acute for ÔomicÕ techniques where the large number of variables maximizes the chances of detecting the effects of potentially confounding influences. It would be valuable for future work both to examine the effects of different growth conditions and also to test a much wider range of isolates with differing phenotypes.
Conclusions
Screening for eleven different suspected virulence genes within genomic DNA was not able to distinguish common laboratory strains of B. cereus, considered generally avirulent, from B. cereus strains isolated from separate meningitis outbreaks. In contrast, NMR-based multivariate metabolite profiling (metabolomics) showed that the two separate bacterial groups were separated on the basis of their biochemical properties. A suitable metabolomic analysis could be used as a possible screening of microbial isolates as part of a test for pathogenic potential. The observed biochemical differences between strains might in future also prove useful in mechanistic experiments, by potentially providing new and testable hypotheses about the physiological and biochemical differences between different bacterial ecotypes.
